The yin and yang of innate immunity in stroke

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Xu, Xiaomeng ^a   Jiang, Yongjun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CYTOKINE; DISUFENTON SODIUM; DNA; ENLIMOMAB; GRANULOCYTE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; PATTERN RECOGNITION RECEPTOR; PLACEBO; PROTEIN S 100; RECOMBINANT PROTEIN; RNA; UK 279,276; UNCLASSIFIED DRUG; URIC ACID;

BLOOD CLOT LYSIS; BRAIN FUNCTION; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CELL ACTIVATION; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DENDRITIC CELL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MICROGLIA; MORTALITY; NERVE CELL LESION; NEUROPROTECTION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RECANALIZATION; REPERFUSION INJURY; REVIEW; ANIMAL; IMMUNOLOGY; PATHOLOGY;

ANIMALS; BRAIN ISCHEMIA; HUMANS; IMMUNITY, INNATE; INFLAMMATION; STROKE;

EID: 84901282569     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/807978     Document Type: Review

References (72)

1. Macrez R., Ali C., Toutirais O., Le Mauff B., Defer G., Dirnagl U., Vivien Denis D., Stroke and the immune system: from pathophysiology to new therapeutic strategies. The Lancet Neurology 2011 10 5 471 480 2-s2.0-79954579638 10.1016/S1474-4422(11)70066-7
2. Jiang Y., Wei N., Lu T., Zhu J., Xu G., Liu X., Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience 2011 172 398 405 2-s2.0-78650748359 10.1016/j.neuroscience.2010.10.054
3. Xu G., Ma M., Liu X., Hankey G. J., Is there a stroke belt in China and why? Stroke-A Journal of Cerebral Circulation 2013 44 7 1775 1783
4. Jiang Y., Zhu W., Zhu J., Wu L., Xu G., Liu X., Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. Cell Transplantation 2013 22 12 2291 2298
5. Lees K. R., Bluhmki E., von Kummer R., Brott T. G., Toni D., Grotta J. C., Albers G. W., Kaste M., Marler J. R., Hamilton S. A., Tilley B. C., Davis S. M., Donnan G. A., Hacke W., Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. The Lancet 2010 375 9727 1695 1703 2-s2.0-77952112006 10.1016/S0140-6736(10)60491-6
6. Fonarow G. C., Smith E. E., Saver J. L., Reeves M. J., Bhatt D. L., Grau-Sepulveda M. V., Olson D. M., Hernandez A. F., Peterson E. D., Schwamm L. H., Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 2011 123 7 750 758 2-s2.0-79952073474 10.1161/CIRCULATIONAHA.110.974675
7. Downes C. E., Crack P. J., Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? British Journal of Pharmacology 2010 160 8 1872 1888 2-s2.0-77954884148 10.1111/j.1476-5381.2010. 00864.x
8. Chamorro A., Meisel A., Planas A. M., Urra X., van de Beek D., Veltkamp R., The immunology of acute stroke. Nature Reviews. Neurology 2012 8 7 401 410
9. Yenari M. A., Kauppinen T. M., Swanson R. A., Microglial activation in stroke: therapeutic targets. Neurotherapeutics 2010 7 4 378 391 2-s2.0-77957088682 10.1016/j.nurt.2010.07.005
10. Courties G., Moskowitz M. A., Nahrendorf M., The innate immune system after ischemic injury: lessons to be learned from the heart and brain. JAMA Neurology 2013 71 2 233 236
11. Lambertsen K. L., Biber K., Finsen B., Inflammatory cytokines in experimental and human stroke. Journal of Cerebral Blood Flow and Metabolism 2012 32 9 1677 1698
12. Schulze J., Zierath D., Tanzi P., Severe stroke induces long-lasting alterations of high-mobility group box 1. Stroke-A Journal of Cerebral Circulation 2013 44 1 246 248
13. Liu K., Mori S., Takahashi H. K., Tomono Y., Wake H., Kanke T., Sato Y., Hiraga N., Adachi N., Yoshino T., Nishibori M., Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. The FASEB Journal 2007 21 14 3904 3916 2-s2.0-36849076615 10.1096/fj.07-8770com (Pubitemid 350232348)
14. Zhang J., Takahashi H. K., Liu K., Wake H., Liu R., Maruo T., Date I., Yoshino T., Ohtsuka A., Mori S., Nishibori M., Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011 42 5 1420 1428 2-s2.0-79955473647 10.1161/STROKEAHA.110.598334
15. Hayakawa K., Miyamoto N., Seo J. H., Pham L. D., Kim K. W., Lo E. H., Arai K., High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter. Journal of Neurochemistry 2013 125 2 273 280
16. Shichita T., Ago T., Kamouchi M., Kitazono T., Yoshimura A., Ooboshi H., Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. Journal of Neurochemistry 2012 123 supplement 2 29 38
17. Hayakawa K., Pham L. D., Arai K., Lo E. H., High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke. Acta Neurochirurgica 2013 118 31 38
18. Iadecola C., Anrather J., The immunology of stroke: from mechanisms to translation. Nature Medicine 2011 17 7 796 808 2-s2.0-79960141471 10.1038/nm.2399
19. Famakin B. M., Mou Y., Johnson K., Spatz M., Hallenbeck J., A new role for downstream Toll-like receptor signaling in mediating immediate early gene expression during focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2014 34 2 258 267
20. Quattromani M. J., Cordeau P., Ruscher K., Kriz J., Wieloch T., Enriched housing down-regulates the Toll-like receptor 2 response in the mouse brain after experimental stroke. Neurobiology of Disease C 2014 66 66 73
21. Tang S. C., Yeh S. J., Li Y. I., Evidence for a detrimental role of TLR8 in ischemic stroke. Experimental Neurology 2013 250 341 347 10.1016/j.expneurol. 2013.10.012
22. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 2-s2.0-32944464648 10.1016/j.cell.2006.02.015 (Pubitemid 43261452)
23. Wang Y.-C., Lin S., Yang Q.-W., Toll-like receptors in cerebral ischemic inflammatory injury. Journal of Neuroinflammation 2011 8, article 134 2-s2.0-80053606159 10.1186/1742-2094-8-134
24. Abe T., Shimamura M., Jackman K., Kurinami H., Anrather J., Zhou P., Iadecola C., Key role of CD36 in toll-like receptor 2 signaling in cerebral ischemia. Stroke 2010 41 5 898 904 2-s2.0-77951767694 10.1161/STROKEAHA.109. 572552
25. Hua F., Ma J., Ha T., Kelley J. L., Kao R. L., Schweitzer J. B., Kalbfleisch J. H., Williams D. L., Li C., Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Research 2009 1262 100 108 2-s2.0-61849088960 10.1016/j.brainres.2009.01.018
26. Saleh M., The machinery of Nod-like receptors: refining the paths to immunity and cell death. Immunological Reviews 2011 243 1 235 246 2-s2.0-80052146101 10.1111/j.1600-065X.2011.01045.x
27. Yang F., Wang Z., Wei X., NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. Journal of Cerebral Blood Flow and Metabolism 2014 34 4 660 667
28. Yang Z., Zhao T., Zhang J. H., Feng H., Curcumin inhibits microglia inflammation and confers neuroprotection in intracerebral hemorrhage. Immunology Letters 2014 14 S0165 S2478 10.1016/j.imlet.2014.03.005
29. Perry V. H., Nicoll J. A. R., Holmes C., Microglia in neurodegenerative disease. Nature Reviews Neurology 2010 6 4 193 201 2-s2.0-77950858637 10.1038/nrneurol.2010.17
30. Yoritsune E., Furuse M., Kuwabara H., Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis. Journal of Radiation Research 2014 10.1093/jrr/rru017
31. Rissanen E., Tuisku J., Rokka J., In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195. Journal of Nuclear Medicine 2014 10.2967/jnumed.113.131698
32. Jin R., Yang G., Li G., Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. Journal of Leukocyte Biology 2010 87 5 779 789 2-s2.0-77952513645 10.1189/jlb.1109766
33. Taylor R. A., Sansing L. H., Microglial responses after ischemic stroke and intracerebral hemorrhage. Clinical & Developmental Immunology 2013 2013 10 746068 10.1155/2013/746068
34. Faustino J. V., Wang X., Johnson C. E., Klibanov A., Derugin N., Wendland M. F., Vexler Z. S., Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. Journal of Neuroscience 2011 31 36 12992 13001 2-s2.0-80052561392 10.1523/JNEUROSCI.2102-11.2011
35. Denes A., Vidyasagar R., Feng J., Narvainen J., McColl B. W., Kauppinen R. A., Allan S. M., Proliferating resident microglia after focal cerebral ischaemia in mice. Journal of Cerebral Blood Flow and Metabolism 2007 27 12 1941 1953 2-s2.0-36249025183 10.1038/sj.jcbfm.9600495 (Pubitemid 350129163)
36. Schroeter M., Jander S., Huitinga I., Stoll G., CD8+ phagocytes in focal ischemia of the rat brain: predominant origin from hematogenous macrophages and targeting to areas of pannecrosis. Acta Neuropathologica 2001 101 5 440 448 2-s2.0-0034956320 (Pubitemid 32600133)
37. Li T., Pang S., Yu Y., Wu X., Guo J., Zhang S., Proliferation of parenchymal microglia is the main source of microgliosis after ischaemic stroke. Brain: A Journal of Neurology 2013 136 12 3578 3588
38. Chiba T., Umegaki K., Pivotal roles of monocytes/macrophages in stroke. Mediators of Inflammation 2013 2013 10 759103 10.1155/2013/759103
39. Easton A. S., Neutrophils and stroke-can neutrophils mitigate disease in the central nervous system? International Immunopharmacology 2013 17 4 1218 1225
40. Morrison H., McKee D., Ritter L., Systemic neutrophil activation in a mouse model of ischemic stroke and reperfusion. Biological Research for Nursing 2011 13 2 154 163 2-s2.0-79952582656 10.1177/1099800410384500
41. Felger J. C., Abe T., Kaunzner U. W., Gottfried-Blackmore A., Gal-Toth J., McEwen B. S., Iadecola C., Bulloch K., Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain, Behavior, and Immunity 2010 24 5 724 737 2-s2.0-77953615767 10.1016/j.bbi.2009.11.002
42. Dietel B., Cicha I., Kallmünzer B., Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke. Experimental Neurology 2012 237 2 379 387
43. Yilmaz A., Fuchs T., Dietel B., Altendorf R., Cicha I., Stumpf C., Schellinger P. D., Blümcke I., Schwab S., Daniel W. G., Garlichs C. D., Kollmar R., Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain. Clinical Science 2010 118 2 147 157 2-s2.0-70549086665 10.1042/CS20090154
44. Kostulas N., Li H.-L., Xiao B.-G., Huang Y.-M., Kostulas V., Link H., Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 2002 33 4 1129 1134 2-s2.0-0036219703 10.1161/hs0402.105379 (Pubitemid 34293602)
45. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.-U., Siler D. A., Arumugam T. V., Orthey E., Gerloff C., Tolosa E., Magnus T., Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009 40 5 1849 1857 2-s2.0-65549130913 10.1161/STROKEAHA.108.534503
46. Parada E., Egea J., Buendia I., The microglial alpha7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2. Antioxidants & Redox Signaling 2013 19 11 1135 1148
47. Lalancette-Hebert M., Swarup V., Beaulieu J. M., Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. The Journal of Neuroscience 2012 32 30 10383 10395
48. Dimitrijevic O. B., Stamatovic S. M., Keep R. F., Andjelkovic A. V., Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007 38 4 1345 1353 2-s2.0-34247874753 10.1161/01.STR.0000259709.16654.8f (Pubitemid 351664259)
49. Hu X., Li P., Guo Y., Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke-A Journal of Cerebral Circulation 2012 43 11 3063 3070
50. Girard S., Brough D., Lopez-Castejon G., Giles J., Rothwell N. J., Allan S. M., Microglia and macrophages differentially modulate cell death after brain injury caused by oxygen-glucose deprivation in organotypic brain slices. Glia 2013 61 5 813 824
51. Cuartero M. I., Ballesteros I., Moraga A., N2 neutrophils, novel players in brain inflammation after stroke modulation by the PPAR γ agonist rosiglitazone. Stroke-A Journal of Cerebral Circulation 2013 44 12 3498 3508
52. Ouyang Y. B., Inflammation and stroke. Neuroscience Letters 2013 548 1 3
53. Galea J., Brough D., The role of inflammation and interleukin-1 in acute cerebrovascular disease. Journal of Inflammation Research 2013 6 121 128
54. Edye M. E., Lopez-Castejon G., Allan S. M., Brough D., Acidosis drives damage-associated molecular pattern (DAMP)-induced interleukin-1 secretion via a caspase-1-independent pathway. The Journal of Biological Chemistry 2013 288 42 30485 30494
55. Shaftel S. S., Carlson T. J., Olschowka J. A., Kyrkanides S., Matousek S. B., O'Banion M. K., Chronic interleukin-1 β expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood-brain barrier permeability without overt neurodegeneration. Journal of Neuroscience 2007 27 35 9301 9309 2-s2.0-34548434392 10.1523/JNEUROSCI.1418-07.2007 (Pubitemid 47358197)
56. Boutin H., LeFeuvre R. A., Horai R., Asano M., Iwakura Y., Rothwell N. J., Role of IL-1 α and IL-1 β in ischemic brain damage. Journal of Neuroscience 2001 21 15 5528 5534 2-s2.0-0035413361 (Pubitemid 32692151)
57. Banwell V., Sena E. S., Macleod M. R., Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. Journal of Stroke and Cerebrovascular Diseases 2009 18 4 269 276 2-s2.0-67649117904 10.1016/j.jstrokecerebrovasdis.2008.11.009
58. Cure M. C., Tufekci A., Cure E., Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke. Annals of Indian Academy of Neurology 2013 16 4 498 503
59. Maddahi A., Kruse L. S., Chen Q. W., Edvinsson L., The role of tumor necrosis factor- α and TNF- α receptors in cerebral arteries following cerebral ischemia in rat. Journal of Neuroinflammation 2011 8, article 107 2-s2.0-80052030139 10.1186/1742-2094-8-107
60. Nawashiro H., Tasaki K., Ruetzler C. A., Hallenbeck J. M., TNF- α pretreatment induces protective effects against focal cerebral ischemia in mice. Journal of Cerebral Blood Flow and Metabolism 1997 17 5 483 490 2-s2.0-0031005797 (Pubitemid 27250974)
61. Biber K., Pinto-Duarte A., Wittendorp M. C., Dolga A. M., Fernandes C. C., Von Frijtag Drabbe Kunzel J., Keijser J. N., De Vries R., Ijzerman A. P., Ribeiro J. A., Eisel U., Sebastião A. M., Boddeke H. W. G. M., Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology 2008 33 9 2237 2250 2-s2.0-47249146449 10.1038/sj.npp.1301612 (Pubitemid 351992084)
62. Jung J. E., Kim G. S., Chan P. H., Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 2011 42 12 3574 3579 2-s2.0-84856209632 10.1161/STROKEAHA.111.626648
63. Clark W. M., Rinker L. G., Lessov N. S., Hazel K., Hill J. K., Stenzel-Poore M., Eckenstein F., Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000 31 7 1715 1720 2-s2.0-0033933545 (Pubitemid 30437528)
64. Gertz K., Kronenberg G., Kälin R. E., Essential role of interleukin-6 in post-stroke angiogenesis. Brain: A Journal of Neurology 2012 135 6 1964 1980
65. Zeng L., Wang Y., Liu J., Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neuroscience Letters 2013 548 4 9 10.1016/j.neulet.2013.04.037
66. Sherman D., Bes A., Easton J. D., Hacke W., Kaste M., Polmar S. H., Zivin J. A., Clark W., Schneider D., Whisnant J., Fieschi C., Miller P., Schoenfeld D., Street J., Albers G., Atkinson R., Biller J., Bruno A., Carpenter D., DeGraba T., Driscoll P., Ellis J., Greenlee R. J., Hess D., Horowitz D. R., Davenport J., Hsu C., Starkman S., Madden K., Pettigrew C., Rosenbaum D., Schim J., Tietjen G., Mansbach H., Edwards K., Webb R., Crisostomo E., Wilterdrink J., Rothrock J., Zweifler R., Dexter J., Horowitz S., Futrell N., Alter M., Ferbert A., Prange H., Wiersbitzky M., Büttner T., Schwartz A., Busse O., Klingelhöfer J., Kaste M., Erilä T., Sivenius J., Sotaniemi K., Liukkonen J., Hedman C., Muuronen A., Rissanen A., Larrue V., Blard J.-M., Caussanel J.-P., Feve J.-R., Moulin T., Mahagne M.-H., Rancurel G., Trouillas P., Weber M., Thomassen L., Rosjø Ø., Johnsen H. J., Kjällman L., Petersson J., Ferrari G., Lagi A., Mamoli A., Re G., Use of anti-ICAM-1 therapy in ischemic stroke: results of the enlimomab acute stroke trial. Neurology 2001 57 8 1428 1434 2-s2.0-0035940577 (Pubitemid 32995724)
67. Krams M., Lees K. R., Hacke W., Grieve A. P., Orgogozo J.-M., Ford G. A., Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 2003 34 11 2543 2548 2-s2.0-0242694372 10.1161/01.STR.0000092527.33910.89 (Pubitemid 37392736)
68. Fraser P. A., The role of free radical generation in increasing cerebrovascular permeability. Free Radical Biology and Medicine 2011 51 5 967 977 2-s2.0-80051667284 10.1016/j.freeradbiomed.2011.06.003
69. Nakase T., Yoshioka S., Suzuki A., Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke. BMC Neurology 2011 11, article 39 2-s2.0-79953103571 10.1186/1471-2377-11-39
70. Lees K. R., Zivin J. A., Ashwood T., NXY-059 for acute ischemic stroke. The New England Journal of Medicine 2006 354 6 588 600 2-s2.0-33646489800 (Pubitemid 43209106)
71. Shuaib A., Lees K. R., Lyden P., Grotta J., Davalos A., Davis S. M., Diener H.-C., Ashwood T., Wasiewski W. W., Emeribe U., NXY-059 for the treatment of acute ischemic stroke. The New England Journal of Medicine 2007 357 6 562 571 2-s2.0-34547795720 10.1056/NEJMoa070240 (Pubitemid 47236281)
72. Emsley H. C. A., Smith C. J., Georgiou R. F., Vail A., Hopkins S. J., Rothwell N. J., Tyrrell P. J., A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. Journal of Neurology, Neurosurgery and Psychiatry 2005 76 10 1366 1372 2-s2.0-25444517949 10.1136/jnnp.2004.054882 (Pubitemid 41360973)